KX0826

DRUG2 trials

Sponsors

Suzhou Kintor Pharmaceutical Inc,

Conditions

Androgenetic Alopecia

Phase 1

the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending

CompletedNCT04502901

Suzhou Kintor Pharmaceutical Inc,Androgenetic Alopecia

Start: 2020-01-14End: 2021-01-15Updated: 2021-08-11

Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration

CompletedNCT04984707

Suzhou Kintor Pharmaceutical Inc,Androgenetic Alopecia

Start: 2019-01-28End: 2019-10-24Updated: 2021-07-30